WENBIT - Western Norway B Vitamin Intervention Trial "WENBIT"


Phase 3 Results

Summary of Purpose

PURPOSE OF STUDY Observational studies have demonstrated that elevated levels of plasma total homocysteine is a risk factor for cardiovascular disease. The purpose of this trial is to evaluate the clinical effects of homocysteine lowering treatment with B vitamins during 3-5 years follow-up of patients undergoing cardiac catheterization for suspected coronary artery disease (CAD). Special attention will be given...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 11 July 2013.

1 Apr 1999 19 Jul 2006 1 Jun 2007 1 Feb 2008 1 May 2010 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Prevention
  • Endpoint: Efficacy Study
  • Intervention: Factorial Assignment


  • Marta Ebbing, MD, Department of Heart Disease, Haukeland University Hospital, Jonas Liesvei 65, 5021 Bergen, Norway (marta .ebbing@helse-bergen.no).